Additionally, recent findings suggest that GLP-1 receptor agonists may ameliorate neurodegeneration in murine models of infantile neuroaxonal dystrophy linked to PLA2G6 [29]. Here, PLA2G6 is linked to neuroaxonal dystrophy.